1Klinik für Allgemeine Pädiatrie, Heinrich-Heine-Universität Düsseldorf. hoffmann@med.uni-duesseldorf.de
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Fabry disease, a genetic disorder, results from alpha-Galactosidase A deficiency, causing globotriaosylceramide buildup. Enzyme replacement therapy (ERT) effectively treats this condition, addressing its severe health impacts.
Area of Science:
Context:
Purpose:
Summary:
Impact: